# Linagliptin and metformin hydrochloride

NDC: 72205-407
Generic name: Linagliptin and metformin hydrochloride
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20251103

FDA application: ANDA208459

## Active ingredients

- LINAGLIPTIN: 2.5 mg/1
- METFORMIN HYDROCHLORIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-407"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-407
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb